BURLINGAME, Calif.--(BUSINESS WIRE)--Humanigen, Inc., (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ...
Poor memory performance was associated with an increased risk for COVID-19 hospitalization and mortality in adults aged 50 years and older.
Treatment options for mild-to-moderate COVID-19 are becoming increasingly well established. A systematic review and network meta-analysis published in The BMJ evaluated 40 treatments across 187 ...
The Minnesota-based Vaccine Integrity Project followed through Tuesday on a promise to provide scientific data on vaccine safety and effectiveness ― with the results contradicting President Donald ...
Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in ...
After an in-depth analysis of the genetic material from hundreds of swabs taken from the walls, floors, machines and drains inside the Huanan Seafood Wholesale Market in Wuhan, China — a site that’s ...
The summer surge of COVID-19 is here, with data from the Centers for Disease Control and Prevention showing increases across much of the country. In its latest report, the CDC said the number of cases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results